What is the appropriate management of Nannizzia (Microsporum) gypseum infection?

Management of Nannizzia gypseum Infection

Oral terbinafine is the treatment of choice for Nannizzia (Microsporum) gypseum infections, using weight-based dosing for 2–4 weeks for uncomplicated cutaneous infections, though more severe presentations may require extended courses up to 8–12 weeks. 1

First-Line Systemic Therapy

Standard Terbinafine Dosing

• Weight-based oral terbinafine is the preferred agent for N. gypseum infections 1:
  • ≤20 kg: 62.5 mg once daily
  • 20–40 kg: 125 mg once daily

  • 40 kg (including adults): 250 mg once daily

  • Duration: 2–4 weeks for uncomplicated tinea corporis/faciei 1

Extended Treatment for Severe Infections

• Kerion and deep cutaneous infections require prolonged therapy of 8–12 weeks 2, 3
• Onychomycosis caused by N. gypseum necessitates 12 weeks of terbinafine (may extend to 18 weeks if initial response inadequate) 4
• Subcutaneous mycosis responds to standard terbinafine dosing but monitor closely for complete remission 5

Alternative Systemic Agents

When to Consider Alternatives

• Itraconazole 100 mg/day for 8 weeks is an effective alternative, particularly for facial involvement near sensitive areas like the eyelid 6
• Griseofulvin can be used but is not specifically superior for N. gypseum (unlike M. canis where it is preferred) 1

Critical Pre-Treatment Steps

Species Identification

• Obtain fungal culture or molecular identification (ITS rDNA sequencing) before initiating therapy to confirm N. gypseum and exclude other dermatophytes requiring different management 1, 6
• Empiric terbinafine is reasonable when clinical features suggest dermatophyte infection (annular erythematous plaques, scaling, kerion formation) while awaiting culture results 1

Baseline Monitoring

• Obtain baseline liver function tests before starting terbinafine due to risk of hepatotoxicity that may progress to liver failure 1
• Warn patients about persistent taste disturbance, which can be permanent 1

Adjunctive Topical Measures

• Antifungal shampoos or topical agents (ketoconazole 2%, selenium sulfide 1%, miconazole cream) reduce spore load and transmission risk but do not replace systemic therapy 1, 7
• Topical therapy alone is insufficient for cure of dermatophyte infections involving hair follicles or deep skin structures 1

Management of Treatment Failure

• If no clinical improvement after standard course: extend therapy to 12–18 weeks or switch to itraconazole 1
• Evaluate adherence, absorption issues, and reinfection sources (soil exposure, carrier animals) 1, 2
• Consider higher doses up to 25 mg/kg/day in resistant cases 1

Source Control and Prevention

Zoonotic Transmission

• Screen household pets (dogs, cats, rodents) for dermatophyte carriage even if asymptomatic, as they serve as reservoirs 2, 8
• Treat carrier animals with chlorhexidine and miconazole baths to prevent reinfection 2
• Avoid soil contact during treatment, as N. gypsea is geophilic and persists in contaminated soil 6, 3

Environmental Decontamination

• Disinfect fomites and personal items that contacted infected skin, including clothing and bedding 3
• Prohibit introduction of outside belongings in healthcare settings to prevent nosocomial transmission 3

Clinical Pitfalls to Avoid

• Do not misdiagnose as pyoderma gangrenosum or other inflammatory dermatoses; N. gypseum can present with pustular folliculitis and subcutaneous nodules mimicking other conditions 5
• Do not use topical steroids or immunosuppressants (cyclosporine) empirically for undiagnosed inflammatory plaques, as this worsens fungal infections 5
• Do not assume infection site predicts source; N. gypseum can infect unusual locations (eyelid, proximal nail fold) through indirect contact, not just direct soil exposure 6, 4
• Do not stop treatment prematurely; onychomycosis requires minimum 12 weeks even if clinical improvement appears earlier 4